Quinazoline derivatives have been reported to exhibit cytotoxic activity against different cancer types via various mechanisms, including the inhibition of; epidermal growth factor receptor (EGFR) [25], or kinesin spindle protein (KSP) [26], interfering with: Wnt signaling pathway [27] and phosphatidylinositol-3-kinase (PI3K) [28], in addition to the downregulation of the antiapoptotic proteins Bcl2 and BclxL [29]. This evidence concerns the gene EGFR and cancer.